It is the world’s first Triple-Hormone Receptor Agonist. While previous medications only targeted one or two pathways, Retatrutide targets the "Triple G" Pathway:
GLP-1: Controls hunger and slows digestion.
GIP: Improves fat and sugar metabolism.
Glucagon: The "secret weapon" that actually increases your body's energy expenditure (calorie burning), even while at rest.
The 24% Breakthrough: In Phase 2 trials, Retatrutide showed a mean weight reduction of 24.2% at the highest dose, the highest percentage ever recorded for a weight-loss drug in this timeframe.
Liver Health Bonus: Research indicates that Retatrutide is exceptionally effective at clearing fat from the liver, showing over 80% reduction in liver fat for many patients.
Comments